Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients
Latest Information Update: 10 Jul 2024
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Folinic acid; Hydrocortisone; Methotrexate; Methotrexate; Methylprednisolone; Prednisolone; Prednisone; Vincristine
- Indications B-cell leukaemia; B-cell lymphoma; Burkitt's lymphoma; Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Acronyms Inter-B-NHL ritux 2010
- 10 Jul 2024 This trial has been completed in Belgium, according to European Clinical Trials Database record.
- 16 Feb 2024 This study has been completed in Poland, according to European Clinical Trials Database record.
- 23 Oct 2023 This study has been completed in Netherland, according to European Clinical Trials Database record.